BIOPROGRESS TECHNOLOGY INTERNATIONAL INC
10QSB, EX-27, 2000-08-14
EATING PLACES
Previous: BIOPROGRESS TECHNOLOGY INTERNATIONAL INC, 10QSB, 2000-08-14
Next: WESCO INTERNATIONAL INC, 10-Q, 2000-08-14



<TABLE> <S> <C>


<ARTICLE> 5

<S>                                             <C>
<PERIOD-TYPE>                                 6-MOS
<FISCAL-YEAR-END>                       DEC-31-2000
<PERIOD-START>                          JAN-01-2000
<PERIOD-END>                            JUN-30-2000
<CASH>                                    4,620,437
<SECURITIES>                                464,101
<RECEIVABLES>                               340,142
<ALLOWANCES>                                      0
<INVENTORY>                                       0
<CURRENT-ASSETS>                          5,424,680
<PP&E>                                    7,806,604
<DEPRECIATION>                                    0
<TOTAL-ASSETS>                           13,231,284
<CURRENT-LIABILITIES>                     1,614,513
<BONDS>                                           0
                             0
                               3,949,207
<COMMON>                                     40,957
<OTHER-SE>                                7,626,607
<TOTAL-LIABILITY-AND-EQUITY>             13,231,284
<SALES>                                      56,786
<TOTAL-REVENUES>                             56,786
<CGS>                                         6,782
<TOTAL-COSTS>                                 6,782
<OTHER-EXPENSES>                          1,306,136
<LOSS-PROVISION>                                  0
<INTEREST-EXPENSE>                                0
<INCOME-PRETAX>                          (1,256,132)
<INCOME-TAX>                                      0
<INCOME-CONTINUING>                               0
<DISCONTINUED>                                    0
<EXTRAORDINARY>                                   0
<CHANGES>                                         0
<NET-INCOME>                             (1,256,132)
<EPS-BASIC>                                   (0.03)
<EPS-DILUTED>                                     0



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission